Risk of dementia in seniors with newly diagnosed diabetes: A Population-Based study

Diabetes Care

Volumn 38, Issue 10, 2015, Pages 1868-1875

  Haroon, Nisha Nigil ^a   Austin, Peter C ^b   Shah, Baiju R ^a,b   Wu, Jianbao ^b   Gill, Sudeep S ^b,c   Booth, Gillian L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DEMENTIA; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HYPOGLYCEMIA; METHODOLOGY; MIDDLE AGED; PSYCHOLOGY; RENAL INSUFFICIENCY, CHRONIC;

AGED; DEMENTIA; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIA; MALE; MIDDLE AGED; ONTARIO; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN;

EID: 84962376094     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0491     Document Type: Article

References (47)

1. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: A population-based study. Lancet 2007;369:750-756.
2. Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: A population-based study. Diabetologia 2013;56:2601-2608.
3. Policy Brief for Heads of Government: The Global Impact of Dementia 2013-2050. Alzheimer's Disease International (ADI), London, December 2013. Available from http://www.alz.co.uk/research/GlobalImpactDementia2013.pdf. Accessed 31 August 2014.
4. Daviglus ML, Plassman BL, Pirzada A, et al. Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol 2011;68:1185-1190.
5. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J 2012;42:484-491.
6. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: A systematic review and meta-analysis. PLoS One 2009;4: E4144.
7. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 2006;5:64-74.
8. Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: The confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 2013;35:152-160.
9. Kimm H, Lee PH, Shin YJ, et al. Mid-life and late-life vascular risk factors and dementia in Korean men and women. Arch Gerontol Geriatr 2011;52:e117-e122.
10. Wang KC, Woung LC, Tsai MT, Liu CC, Su YH, Li CY. Risk of Alzheimer's disease in relation to diabetes: A population-based cohort study. Neuroepidemiology 2012;38: 237-244.
11. Huang CC, Chung CM, Leu HB, et al. Diabetes mellitus and the risk of Alzheimer's disease: A nationwide population-based study. PLoS One 2014;9:e87095.
12. Pilcher H. Alzheimer's disease could be "type 3 diabetes". Lancet Neurol 2006;5:388- 389.
13. Strachan MW, Reynolds RM, Marioni RE, Price JF. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 2011;7:108-114.
14. Schrijvers EM, Witteman JC, Sijbrands EJ, Hofman A, Koudstaal PJ, Breteler MM. Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study. Neurology 2010;75:1982- 1987.
15. Talbot K, Wang HY, Kazi H, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122:1316-1338.
16. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-516.
17. St Germaine-Smith C, Metcalfe A, Pringsheim T, et al. Recommendations for optimal ICD codes to study neurologic conditions: A systematic review. Neurology 2012;79:1049-1055.
18. Gill SS, Camacho X, Poss JW. Communitydwelling older adults with dementia: Tracking encounters with the health system. In Health System Use by Frail Ontario Seniors: An In-Depth Examination of Four Vulnerable Cohorts. Bronskill SE, Camacho X, Gruneir A, Ho MM, Eds. Toronto, ON, Institute for Clinical Evaluative Sciences, 2011.
19. Al-Omran M, Mamdani MM, Lindsay TF, Melo M, Juurlink DN, Verma S; Systematic Assessment of Vascular Risk Investigators. Suboptimal use of statin therapy in elderly patients with atherosclerosis: A population-based study. J Vasc Surg 2008;48:607-612.
20. Seitz DP, Gill SS, Bell CM, et al. Postoperative medical complications associated with anesthesia in older adults with dementia. J Am Geriatr Soc 2014;62:2102-2109.
21. Tu K, Campbell NR, Chen ZL, Cauch-Dudek KJ, McAlister FA. Accuracy of administrative databases in identifying patients with hypertension. Open Med 2007;1:e18-e26.
22. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with nondiabetic people: A population-based retrospective cohort study. Lancet 2006;368:29-36.
23. Booth GL, Lipscombe LL, Degani N, et al. Diabetes. In Project for an Ontario Women's Health Evidence-Based Report. Vol. 2. Bierman AS, editor. Toronto, St. Michael's Hospital and the Institute for Clinical Evaluative Sciences, 2010.
24. Ronksley PE, Tonelli M, Quan H, et al.; Alberta Kidney Disease Network. Validating a case definition for chronic kidney disease using administrative data. Nephrol Dial Transplant 2012; 27:1826-1831.
25. Shah BR, Victor JC, Chiu M, et al. Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: A population-based cohort study. Diabetes Care 2013;36:2670-2676.
26. Okrainec K, Booth GL, Hollands S, Bell CM. Impact of language barriers on complications and mortality among immigrants with diabetes: A population-based cohort study. Diabetes Care 2015;38:189-196.
27. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009;170:244-256.
28. Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: A cohort study. Lancet Diabetes Endocrinol 2013;1:183-190.
29. Bruce DG, Davis WA, Starkstein SE, Davis TM. Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: The Fremantle Diabetes Study. J Alzheimers Dis 2014;42(Suppl.3):S63-S70.
30. Kelleher RJ, Soiza RL. Evidence of endothelial dysfunction in the development of Alzheimer's disease: is Alzheimer's a vascular disorder? Am J Cardiovasc Dis 2013;3:197-226.
31. Tzourio C, Anderson C, Chapman N, et al.; PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-1075.
32. Launer LJ, Miller ME, Williamson JD, et al.; ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy. Lancet Neurol 2011;10:969-977.
33. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301: 1565-1572.
34. Yaffe K, Falvey CM, Hamilton N, et al.; Health ABC Study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013;173:1300-1306.
35. Llibre Rodriguez JJ, Ferri CP, Acosta D, et al.; 10/66 Dementia Research Group. Prevalence of dementia in Latin America, India, and China: A population-based cross-sectional survey. Lancet 2008;372:464-474.
36. Booth GL, Bishara P, Lipscombe LL, et al. Universal drug coverage and socioeconomic disparities in major diabetes outcomes. Diabetes Care 2012;35:2257-2264.
37. Booth GL, Creatore MI, Moineddin R, et al. Unwalkable neighborhoods, poverty, and the risk of diabetes among recent immigrants to Canada compared with long-term residents. Diabetes Care 2013;36:302-308.
38. Rosella LC, Manuel DG, Burchill C, Stukel TA; PHIAT-DM team. A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Community Health 2011;65:613-620.
39. Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement 2015;11:718-726.
40. Di Marco LY, Marzo A, Munoz-Ruiz M, et al. Modifiable lifestyle factors in dementia: A systematic review of longitudinal observational cohort studies. J Alzheimers Dis 2014;42:119- 135.
41. Janz T. Statistics Canada. Health at a glance: current smoking trends. Available from http://www.statcan.gc.ca/pub/82-624-x/2012001/article/11676-eng.htm. Accessed 2 June 2015.
42. McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev 2009;15: CD003160.
43. Anderson C, Teo K, Gao P, et al.; ONTARGET and TRANSCEND Investigators. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: Analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 2011;10: 43-53.
44. Williamson JD, Launer LJ, Bryan RN, et al.; Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Investigators. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: A randomized clinical trial. JAMA Intern Med 2014;174:324-333.
45. Peters R, Beckett N, Forette F, et al.; HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial. Lancet Neurol 2008;7: 683-689.
46. Hsu CC, Wahlqvist ML, Lee MS, Tsai HN. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 2011;24: 485- 493.
47. Peters R, Booth A, Peters J. A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly. J Hypertens 2014;32:1945-1957; discussion 1957-1958.